Nanocarriers-Assisted Nose-to-Brain Delivery of Levodopa: Current Progress and Prospects
A challenge to contemporary medicine is still the discovery of an effective and safe therapy for symptomatic control, if not cure, of Parkinson’s disease. While the potential century’s break-through is sought and foreseen by many scientists in gene therapy, immunotherapy, new drug combinations, and...
Saved in:
Main Authors: | Mariya Dangova, Nadezhda Ivanova, Velichka Andonova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/15/1/331 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug utilization study of antiparkinsonian medication in Romania during 25 years
by: Camelia Bucsa, et al.
Published: (2025-02-01) -
Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications
by: Hugo Felix Perini, et al.
Published: (2024-12-01) -
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
by: Fatih Ciftci, et al.
Published: (2025-01-01) -
Avaliação da extração sólido-líquido de levodopa a partir de sementes de mucuna utilizando diferentes solventes
by: Rita de Cássia Superbi de Sousa, et al.
Published: (2024-02-01) -
Synergistic action of propolis with levodopa in the management of Parkinsonism in Drosophila melanogaster
by: Herbert Izo, Ninsiima, et al.
Published: (2020)